Pregnancy in renal transplant recipients

Dialysis and Transplantation

Volumn 39, Issue 11, 2010, Pages 472-475

  McKay, Dianne B ^a   Josephson, Michelle ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; METHYLDOPA; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL CONTRACEPTIVE AGENT; PREDNISONE; RITUXIMAB; THIAZIDE DIURETIC AGENT; VALGANCICLOVIR;

BREAST FEEDING; CONTRACEPTION; DRUG EXPOSURE; FERTILITY; FETUS MALFORMATION; FETUS OUTCOME; GRAFT RECIPIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MATERNAL CARE; NONHUMAN; ORAL CONTRACEPTION; PATIENT COUNSELING; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UNSPECIFIED SIDE EFFECT;

EID: 78649265032     PISSN: 00902934     EISSN: 19326920     Source Type: Journal    
DOI: 10.1002/dat.20511     Document Type: Review

References (48)

1. McKay DB, Josephson MA,. 2006. Pregnancy in recipients of solid organs-effects on mother and child. N Engl J Med. 2006; 354: 1281 - 1293.
2. McKay D, Josephson M,. Reproduction and trans-plantation: report on the AST consensus confer-ence on reproductive issues and transplantation. Am J Transplantation. 2005; 5: 1 - 8.
3. Lim VS,., Henriquez C, Sievertsen G, Frohman LA,. Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation. Ann Intern Med. 1980; 93: 21 - 27.
4. Josephson MA, McKay DB,. Considerations in the medical management of pregnancy in transplant recipients. Adv Chronic Kidney Dis. 2007; 14: 156 - 167.
5. Gill JS, Zalunardo N, Rose C, Tonelli M,. The pregnancy rate and live birth rate in kidney trans-plant recipients. Am J Transplant. 2009; 9: 1541 - 1549.
6. Zeyneloglu HB, Oktem M, Durak T,. Male infertility after renal transplantation: achievement of preg-nancy after intracytoplasmic sperm injection. Transplant Proc. 2005; 37: 3081 - 3084.
7. Douglas NC, Shah M, Sauer MV,. Fertility and repro-ductive disorders in female solid organ transplant recipients. Semin Perinatol. 2007; 31: 332 - 338.
8. Ulug U, Mesut A, Jozwiak EA, Bahceci M,. Suc-cessful pregnancy in a liver transplant recipient following controlled ovarian hyperstimulation and intracytoplasmic sperm injection. J Assist Reprod Genet. 2005; 22: 311 - 313.
9. Pietrzak B, Bobrowska K, Jabiry-Zieniewicz Z, et al. Oral and transdermal hormonal contraception in women after kidney transplantation. Transplant Proc. 2007; 39: 2759 - 2762.
10. Tracy TS, Venkataramanan R, Glover DD, Caritis SN,. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol. 2005; 192: 633 - 639.
11. McKay DB, Josephson MA,. Pregnancy after kidney transplantation. Clin J Am Soc Nephrol. 2008; 3 (suppl 2): S117 - S125.
12. Stringer EM, Kaseba C, Levy J, et al. A randomized trial of the intrauterine contraceptive device vs hor-monal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007; 197: 144 e141 - 148.
13. Zerner J, Doil KL, Drewry J, Leeber DA,. Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med. 1981; 26: 99 - 102.
14. Armenti VT, Radomski JS, Moritz MJ, Branch KR, McGrory CH, Coscia LA,. Report from the National Transplantation Pregnancy Registry (NTPR): out-comes of pregnancy after transplantation. Clinical Transplant. 2007. 1998 1997: 101 - 112.
15. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Reg-istry (NTPR): outcomes of pregnancy after trans-plantation. Clinical Transplant. 2005; 103 - 119.
16. Armenti VT, Radomski JS, Moritz MJ, Gaughan WJ, McGrory CH, Coscia LA,. Report from the National Transplantation Pregnancy Registry (NTPR): out-comes of pregnancy after transplantation. Clinical Transplant. 2004; 131 - 141.
17. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the national transplantation pregnancy reg-istry (NTPR): outcomes of pregnancy after trans-plantation. Clinical Transplant. 2001; 97 - 105.
18. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Reg-istry (NTPR): outcomes of pregnancy after trans-plantation. Clinical Transplant. 2002; 121 - 130.
19. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Reg-istry (NTPR): outcomes of pregnancy after trans-plantation. Clinical Transplant. 2003; 121 - 130.
20. Armenti VT, Wilson GA, Radomski JS, Moritz MJ, McGrory CH, Coscia LA,. Report from the National Transplantation Pregnancy Registry (NTPR): out-comes of pregnancy after transplantation. Clinical Transplant. 2000; 111 - 119.
21. Coscia LA, Constantinescu S, Moritz MJ, et al. Report from the National Transplantation Preg-nancy Registry (NTPR): outcomes of pregnancy after transplantation. Clinical Transplant. 2008; 89 - 105.
22. Coscia LA, Constantinescu S, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of preg-nancy after transplantation. Clinical Transplant. 2007 29 - 42.
23. Cossio L, Armenti VT,. A report from the National Transplantation Pregnancy Registry. Clinical Trans-plant. 2004; 131 - 141.
24. Radomski JS, Ahlswede BA, Jarrell BE, et al. Out-comes of 500 pregnancies in 335 female kidney, liver, and heart transplant recipients. Transplant Proc. 1995; 27: 1089 - 1090.
25. Sibanda N, Briggs JD, Davison JM, Johnson RJ, Rudge CJ,. Outcomes of pregnancy after renal transplantation: a report of UK Transplant Pregnancy Registry. Hypertens Pregnancy. 2004; 23 (suppl 1): 136.
26. Stratta P, Canavese C, Giacchino F, Mesiano P, Quaglia M, Rossetti M,. Pregnancy in kid-ney transplantation: satisfactory outcomes and harsh realities. J Nephrol. 2003; 16: 792 - 806.
27. Laube GF, Kemper MJ, Schubiger G, Neuhaus TJ,. Angiotensin-converting enzyme inhibitor fetopa-thy: long-term outcome. Arch Dis Child Fetal Neonatal Ed. 2007; 92: F402 - 403.
28. Tabacova S,. Mode of action: angiotensin-con-verting enzyme inhibition-developmen tal effects associated with exposure to ACE inhibitors. Crit Rev Toxicol. 2005; 35: 747 - 755.
29. Hertig A, Watnick S, Strevens H, Boulanger H, Berkane H, Rondeau E,. How should women with pre-eclampsia be followed up? New insights from mechanistic studies. Nat Clin Pract Nephrol. 2008; 4: 503 - 509.
30. Davison JM, Baylis C,. Pregnancy in patients with underlying renal disease. In:, Davison JM, Cam-eron JS, Ritz E, et al., eds. Oxford Textbook of Nephrology. Oxford: Oxford University Press; 2004; 2243 - 2260.
31. Davison JM, Bailey DJ,. Pregnancy following renal transplantation. J Obstet Gynaecol Res. 2003; 29: 227 - 233.
32. Sifontis NM, Coscia LA, Constantinescu S, Lavel-anet AF, Moritz MJ, Armenti VT,. Pregnancy out-comes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006; 82: 1698 - 1702.
33. LeRay C, Coulomb A, Elefant E, Frydman R, Audi-bert R,. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal mal-formations. Obstet Gyncecol. 2004; 103: 1091 - 1094.
34. Pergola PE, Kancharla A, Riley DJ,. Kidney trans-plantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. Transplantation. 2000; 71: 994 - 997.
35. Pickrell MD, Sawers R, Michael J,. Pregnancy after renal transplantation: severe intrauterine growth retardation during treatment with cyclosporin A. BMJ. 1988; 296: 825 - 829.
36. Gluckman PD, Hanson MA,. The consequences of being born small-an adaptive perspective. Horm Res. 2006; 65 (suppl 3): 5 - 14.
37. Saenger P, Czernichow P, Hughes I, Reiter EO,. Small for gestational age: short stature and beyond. Endocr Rev. 2007; 28: 219 - 251.
38. Wallace IF, McCarton CM,. Neurodevelopmental outcomes of the premature, small-for-gestational-age infant through age 6. Clin Obstet Gynecol. 1997; 40: 843 - 852.
39. Neubauer AP, Voss W, Kattner E,. Outcome of extremely low birth weight survivors at school age: the influence of perinatal parameters on neurodevelopment. Eur J Pediatr. 2008; 167: 87 - 95.
40. Reyes L, Manalich R,. Long-term consequences of low birth weight. Kidney Int Suppl. 2005; S107 - 111.
41. Taylor HG, Minich N, Bangert B, Filipek PA, Hack M,. Long-term neuropsychological outcomes of very low birth weight: associations with early risks for periventricular brain insults. J Int Neuropsychol Soc. 2004; 10: 987 - 1004.
42. Victor RG, Thomas GD, Marban E, O'Rourke B,. Presynaptic modulation of cortical synaptic activity by calcineurin. Proc Natl Acad Sci U S A. 1995; 92: 6269 - 6273.
43. Classen JB, Shevach EM,. Evidence that cyclospo-rine treatment during pregnancy predisposes off-spring to develop autoantibodies. Tranplantation 1991; 51: 1052 - 1057.
44. Pilarski LM, Yacyshyn BR, Lazarovits AI,. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclo-sporine or to azathioprine in utero. Transplantation. 1994; 57: 133 - 144.
45. Sakaguchi S, Sakaguchi N,. Organ-specific autoim-mune disease induced in mice by elimination of T cell subsets. V: Neonatal administration of cyclo-sporin A causes autoimmune disease. J Immunol. 1989; 142: 471 - 479.
46. American Association of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human breast milk. Pediatrics. 1989; 4: 924 - 936.
47. Moretti ME, Sgro M, Johnson DW, et al. Cyclospo-rine excretion into breast milk. Transplantation. 2003; 75: 2144 - 2146.
48. Ross LF,. Ethical considerations related to preg-nancy in transplant recipients. N Engl J Med. 2006; 354: 1313 - 1316.